This is a working overview of nuclear receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-31. Anything still debated is marked as such rather than presented as settled.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
At the molecular level, SR9009 binds REV-ERBα and REV-ERBβ and alters their repressive activity on target genes. These nuclear receptors help regulate the circadian clock, lipid synthesis, glucose metabolism, and inflammatory pathways. By changing transcription, the compound can shift the timing or magnitude of downstream metabolic processes in model systems. It does not act through androgen receptors or adenosine receptors, which distinguishes it from several substances sold for athletic performance. Whether the same transcriptional changes occur in humans at tolerable exposures remains an open question because controlled human studies are lacking.
Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
== Choanoflagellates == All animals are posited to have evolved from a flagellated eukaryote. Their closest known living relatives are the choanoflagellates, collared flagellates whose cell morphology is similar to the choanocyte cells of certain sponges. Molecular studies place animals in a supergroup called the opisthokonts, which also includes the choanoflagellates, fungi, and a few small parasitic protists. The name comes from the posterior location of the flagellum in motile cells, such as most animal spermatozoa, whereas other eukaryotes tend to have anterior flagella instead.
Sinosauropteryx (meaning "Chinese reptilian wing") is an extinct genus of coelurosaurian theropod dinosaurs. Described in 1996, it was the first dinosaur taxon outside of Avialae (birds and their immediate relatives) to be found with evidence of feathers. It was covered with a coat of very simple filament-like feathers. Structures that indicate the colour pattern have also been preserved in some of its feathers, which show that Sinosauropteryx had a countershading pattern in its body with a banded tail. The reddish brown colouration previously inferred for Sinosauropteryx is based on the melanosomes preserved in the specimen of a separate genus, Huadanosaurus. Some contention has arisen with an alternative interpretation of the filamentous impression as remains of collagen fibres, but this has not been widely accepted. Sinosauropteryx was a small theropod with an unusually long tail and short arms. The longest known specimen reaches up to 1.07 metres (3.51 feet) in length, with an estimated weight of 0.55 kilograms (1.21 pounds). It was considered a close relative of the similar but older genus Compsognathus, with both genera belonging to the family Compsognathidae, though subsequent analyses did not recover this family to be monophyletic and placed Sinosauropteryx within its own family, Sinosauropterygidae. Two species of Sinosauropteryx have been named. The first, S. prima, is known from three specimens, named "first" in reference to its status as the first feathered non-avian dinosaur species discovered.
=== Contract-work mods === Oct. 1997: Soldier of Fortune (Quake single player mod for Rysher Entertainment based on the television series Soldier of Fortune, Inc.) Dec. 1997: Soldier of Fortune: Deathmatch (Quake multiplayer mod for Rysher Entertainment) Apr. 1998: Soldier of Fortune: Mission 2 (Quake II single player mod for Rysher Entertainment) Jul. 1998: Coconut Monkey: Paradise Lost (Quake II single player mod for PC Gamer) Sep. 1998: Special Ops Force: Mission 3 -- Desert Bloom (Quake II single player mod for Rysher Entertainment serving as a continuation of the Soldier of Fortune series upon the renaming of the original series by Rysher) Oct. 1998: Coconut Monkey: Dry Gulch (Quake II single player mod for PC Gamer) Dec. 1998: Special Ops Force: Mission 4 -- Cold as Ice (Quake II single player mod for Rysher Entertainment) Jan. 1999: Coconut Monkey: Saving Private Monkey (Quake II single player mod for PC Gamer) Aug. 1999: USS Darkstar (Half-Life single player mod for PC Gamer) Sep. 2000: They Hunger 2: Rest in Pieces (Half-Life single player mod for PC Gamer) Nov. 2000: Vidar's Niflheim (Half-Life multiplayer TFC map for CNET Gamecenter [later updated to Vidar's Niflheim 2]) Jun. 2001: They Hunger 3: Rude Awakening (Half-Life single player mod for PC Gamer) Sep. 2003: Underworld: Bloodline (Half-Life multiplayer mod for Sony Pictures and Big Spaceship LLC based on the Underworld film series)
Augustus exiled his daughter Julia, guilty of "excessive sentimental vivacity", to Reggio. In 61 Paul the Apostle passed through Reggio on his way to Rome. Christianity spread in Calabria to the port centers and along the Via Popilia, vital areas of the Roman region. Emperor Trajan opened the Via Traiana during his rule, roughly traced by State Road 18 Tirrena halfway up the coast. In 305 Calabrian patrician Bulla rebelled against the Roman Empire with 600 horsemen and 5,000 infantry. He was defeated by the imperial militia, but Rome never fully controlled the forests of Sila. On October 1, 313 Constantine I promulgated the Edict of Milan in favor of Christianity, which began to spread. In 391 Emperor Theodosius I proclaimed Christianity the state religion. In 363 Basil the Great landed in Caesarea. His disciples founded various monasteries and cenobia beginning in the ninth century, laying the foundations of the Calabrian-Greek monastic tradition. In 365 an earthquake accompanied by a tidal wave shook the southern Mediterranean, affecting Calabria's coastal towns. The Roman Empire split into two branches. The Western branch, ruled by Honorius with its capital in Ravenna, suffered in 410 the invasion of Alaric's Visigoths, who sacked Rome and marched south. Legend has it that Alaric died in Cosenza, buried at the confluence of the Crati and Busento under the two rivers.
Sources: en.wikipedia.org
== Personal life == On 6 March 2024, al-Burhan's son, Mohammed Fattah Burhan Rahman, was severely injured after his motorcycle collided with another vehicle in Ankara, Turkey. He died of his injuries on 3 May after spending nearly two months in intensive care.
Southern Kuriles / Northern Territories: A Stumbling-block in Russia-Japan Relationship, history and analysis by Andrew Andersen, Department of Political Science, University of Victoria, May 2001 http://depts.washington.edu/ikip/index.shtml (Kuril Island Biocomplexity Project) Kuril Islands at Ocean Dots.com at the Wayback Machine (archived 23 December 2010) (includes space imagery) Kuril Islands at Natural Heritage Protection Fund The International Kuril Island Project http://www.mofa.go.jp/region/europe/russia/territory/index.html Chishima: Frontiers of San Francisco Treaty in Hokkaido Short film on the disputed islands from a Japanese perspective USGS Map showing location of Magnitude 8.3 Earthquake 46.616°N, 153.224°E Kuril Islands region, November 15, 2006 11:14:16 UTC Pictures of Cats – Kurilian Bobtail Pictures of Kuril Islands Kuril Islands at Encyclopædia Britannica
The transduction of the signal through the membrane by the receptor is not completely understood. It is known that in the inactive state, the GPCR is bound to a heterotrimeric G protein complex. Binding of an agonist to the GPCR results in a conformational change in the receptor that is transmitted to the bound Gα subunit of the heterotrimeric G protein via protein domain dynamics. The activated Gα subunit exchanges GTP in place of GDP which in turn triggers the dissociation of Gα subunit from the Gβγ dimer and from the receptor. The dissociated Gα and Gβγ subunits interact with other intracellular proteins to continue the signal transduction cascade while the freed GPCR is able to rebind to another heterotrimeric G protein to form a new complex that is ready to initiate another round of signal transduction. It is believed that a receptor molecule exists in a conformational equilibrium between active and inactive biophysical states. The binding of ligands to the receptor may shift the equilibrium toward the active receptor states. Three types of ligands exist: Agonists are ligands that shift the equilibrium in favour of active states; inverse agonists are ligands that shift the equilibrium in favour of inactive states; and neutral antagonists are ligands that do not affect the equilibrium. It is not yet known how exactly the active and inactive states differ from each other.
11-Aminoundecanoic acid is an organic compound with the formula H2N(CH2)10CO2H. This compound is classified as an amine and a fatty acid. 11-Aminoundecanoic acid is a precursor to Nylon-11. 11-Aminoundecanoic acid is a white crystalline and odorless solid with low solubility in water. As practiced by Arkema, 11-aminoundecanoic acid is prepared industrially from undecylenic acid, which is derived from castor oil. The synthesis proceeds in four separate reactions: Crude castor oil consists of about 80% triglycerides, from the ricinoleic acid, itself representing about 90% of the oil. It is quantitatively transesterified with methanol to methyl ricinoleate (the methyl ester of ricinoleic acid) in the presence of the basic sodium methoxide at 80 °C within 1 h reaction time in a stirred reactor.
Anne Ferguson (26 July 1941 – 21 December 1998) was a Scottish physician, clinical researcher and expert in inflammatory bowel disease. She was considered one of the most distinguished gastroenterologists in Britain. Anne Glen was born in Glasgow in 1941. Her parents were Monica and John Glen. She was educated at Notre Dame High School and the University of Glasgow, graduating with a first class honours BSc in physiology in 1961, followed in 1964 with a MB ChB with honours. She won the Brunton Medal for the most distinguished graduate in medicine at the university.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
SR9009 is a synthetic REV-ERB agonist used in laboratory research. It is not an approved drug, and its effects in humans are not well characterized. It is often sold as a research chemical under the name Stenabolic.